STAI vs. BNGO, PRPO, ASTC, TLIS, AXDX, SMIT, SPEC, TBIO, THMO, and HTGMQ
Should you be buying Scantech AI Systems stock or one of its competitors? The main competitors of Scantech AI Systems include Bionano Genomics (BNGO), Precipio (PRPO), Astrotech (ASTC), Talis Biomedical (TLIS), Accelerate Diagnostics (AXDX), Schmitt Industries (SMIT), Spectaire (SPEC), Telesis Bio (TBIO), ThermoGenesis (THMO), and HTG Molecular Diagnostics (HTGMQ). These companies are all part of the "measuring and control equipment" industry.
Scantech AI Systems vs.
Scantech AI Systems (NASDAQ:STAI) and Bionano Genomics (NASDAQ:BNGO) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.
74.0% of Scantech AI Systems shares are held by institutional investors. Comparatively, 11.4% of Bionano Genomics shares are held by institutional investors. 22.8% of Scantech AI Systems shares are held by insiders. Comparatively, 1.6% of Bionano Genomics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Bionano Genomics had 5 more articles in the media than Scantech AI Systems. MarketBeat recorded 8 mentions for Bionano Genomics and 3 mentions for Scantech AI Systems. Bionano Genomics' average media sentiment score of 0.64 beat Scantech AI Systems' score of 0.15 indicating that Bionano Genomics is being referred to more favorably in the news media.
Scantech AI Systems has a beta of -0.21, suggesting that its share price is 121% less volatile than the S&P 500. Comparatively, Bionano Genomics has a beta of 2.36, suggesting that its share price is 136% more volatile than the S&P 500.
Scantech AI Systems has a net margin of 0.00% compared to Bionano Genomics' net margin of -407.34%. Scantech AI Systems' return on equity of 0.00% beat Bionano Genomics' return on equity.
Bionano Genomics received 164 more outperform votes than Scantech AI Systems when rated by MarketBeat users.
Bionano Genomics has a consensus price target of $7.33, suggesting a potential upside of 102.58%. Given Bionano Genomics' stronger consensus rating and higher probable upside, analysts clearly believe Bionano Genomics is more favorable than Scantech AI Systems.
Scantech AI Systems has higher earnings, but lower revenue than Bionano Genomics.
Summary
Bionano Genomics beats Scantech AI Systems on 8 of the 14 factors compared between the two stocks.
Get Scantech AI Systems News Delivered to You Automatically
Sign up to receive the latest news and ratings for STAI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Scantech AI Systems Competitors List
Related Companies and Tools
This page (NASDAQ:STAI) was last updated on 5/22/2025 by MarketBeat.com Staff
